Menin-MLL
Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.
Products for Menin-MLL
- Cat.No. Product Name Information
- GC11837 MI-136 menin-MLL interaction inhibitor
- GC11418 MI-2 An inhibitor of menin-MLL fusion protein interactions
- GC10388 MI-2 (hydrochloride) menin-MLL interaction inhibitor
- GC12199 MI-3 An inhibitor of menin-MLL fusion protein interactions
- GC12173 MI-nc (hydrochloride) weak inhibitor of menin-MLL interaction